We've found
7,522
archived clinical trials in
Chronic Pain
We've found
7,522
archived clinical trials in
Chronic Pain
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Updated: 12/31/1969
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
Updated: 12/31/1969
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
Status: Enrolling
Updated: 12/31/1969
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
Updated: 12/31/1969
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC)
Updated: 12/31/1969
The Influence of TENS on Mucositis Pain and Function in Head and Neck Cancer Patients: A Randomized and Placebo-Controlled Double Blind Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC)
Updated: 12/31/1969
The Influence of TENS on Mucositis Pain and Function in Head and Neck Cancer Patients: A Randomized and Placebo-Controlled Double Blind Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A
Updated: 12/31/1969
PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [(11)C]NOP-1A
Status: Enrolling
Updated: 12/31/1969
PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A
Updated: 12/31/1969
PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [(11)C]NOP-1A
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Care Management for the Effective Use of Opioids
Updated: 12/31/1969
Care Management for the Effective Use of Opioids (CAMEO)
Status: Enrolling
Updated: 12/31/1969
Care Management for the Effective Use of Opioids
Updated: 12/31/1969
Care Management for the Effective Use of Opioids (CAMEO)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Internet Intervention for Adolescents With Chronic Pain
Updated: 12/31/1969
Web-MAP 2: Internet Intervention for Adolescents With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Internet Intervention for Adolescents With Chronic Pain
Updated: 12/31/1969
Web-MAP 2: Internet Intervention for Adolescents With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effectiveness of Celecoxib After Surgical Sperm Retrieval
Updated: 12/31/1969
The Use of Celecoxib (Celebrex (c)) in Post-operative Pain Control After Microdissection Testicular Sperm Extraction
Status: Enrolling
Updated: 12/31/1969
Effectiveness of Celecoxib After Surgical Sperm Retrieval
Updated: 12/31/1969
The Use of Celecoxib (Celebrex (c)) in Post-operative Pain Control After Microdissection Testicular Sperm Extraction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metabolism and Toxicity of Acetaminophen
Updated: 12/31/1969
Metabolism and Toxicity of Acetaminophen in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Metabolism and Toxicity of Acetaminophen
Updated: 12/31/1969
Metabolism and Toxicity of Acetaminophen in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metabolism and Toxicity of Acetaminophen
Updated: 12/31/1969
Metabolism and Toxicity of Acetaminophen in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Metabolism and Toxicity of Acetaminophen
Updated: 12/31/1969
Metabolism and Toxicity of Acetaminophen in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparison of Two Lidocaine Administration Techniques
Updated: 12/31/1969
Comparison of Two Lidocaine Administration Techniques
Status: Enrolling
Updated: 12/31/1969
Comparison of Two Lidocaine Administration Techniques
Updated: 12/31/1969
Comparison of Two Lidocaine Administration Techniques
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Impact of Exercise Training on Pain and Brain Function in Gulf War Veterans
Updated: 12/31/1969
Impact of Exercise Training on Pain and Brain Function in Gulf War Veterans
Status: Enrolling
Updated: 12/31/1969
Impact of Exercise Training on Pain and Brain Function in Gulf War Veterans
Updated: 12/31/1969
Impact of Exercise Training on Pain and Brain Function in Gulf War Veterans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acupuncture to Reduce Signs of Inflammation in Participants With Chronic Low Back Pain
Updated: 12/31/1969
A Pilot Study to Evaluate the Effect of Acupuncture on Epigenetic Regulation of Inflammatory Mediators in Participants With Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Acupuncture to Reduce Signs of Inflammation in Participants With Chronic Low Back Pain
Updated: 12/31/1969
A Pilot Study to Evaluate the Effect of Acupuncture on Epigenetic Regulation of Inflammatory Mediators in Participants With Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Remote Ischemic PreConditioning Effect on Postsurgical Pain
Updated: 12/31/1969
Remote Ischemic Preconditioning (RIPC) and Its Effect on the Postoperative Pain Experience Following Intra-abdominal Surgery
Status: Enrolling
Updated: 12/31/1969
Remote Ischemic PreConditioning Effect on Postsurgical Pain
Updated: 12/31/1969
Remote Ischemic Preconditioning (RIPC) and Its Effect on the Postoperative Pain Experience Following Intra-abdominal Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks
Updated: 12/31/1969
Continuous Interscalene Block (CISB) Versus Single Injection Interscalene Block in Those Undergoing Shoulder Surgery in the Ambulatory Setting
Status: Enrolling
Updated: 12/31/1969
Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks
Updated: 12/31/1969
Continuous Interscalene Block (CISB) Versus Single Injection Interscalene Block in Those Undergoing Shoulder Surgery in the Ambulatory Setting
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks
Updated: 12/31/1969
Continuous Interscalene Block (CISB) Versus Single Injection Interscalene Block in Those Undergoing Shoulder Surgery in the Ambulatory Setting
Status: Enrolling
Updated: 12/31/1969
Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks
Updated: 12/31/1969
Continuous Interscalene Block (CISB) Versus Single Injection Interscalene Block in Those Undergoing Shoulder Surgery in the Ambulatory Setting
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pain and Function After Orthopedic Surgery
Updated: 12/31/1969
Pain and Function After Orthopedic Surgery
Status: Enrolling
Updated: 12/31/1969
Pain and Function After Orthopedic Surgery
Updated: 12/31/1969
Pain and Function After Orthopedic Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Updated: 12/31/1969
Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity
Status: Enrolling
Updated: 12/31/1969
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Updated: 12/31/1969
Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Intravenous Hydromorphone in Elderly Emergency Department Patients With Acute Severe Pain
Updated: 12/31/1969
Safety and Efficacy of Intravenous Hydromorphone Using Incremental Doses of 0.5 mg in Elderly ED Patients With Acute Severe Pain
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Intravenous Hydromorphone in Elderly Emergency Department Patients With Acute Severe Pain
Updated: 12/31/1969
Safety and Efficacy of Intravenous Hydromorphone Using Incremental Doses of 0.5 mg in Elderly ED Patients With Acute Severe Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Genetics and Pain Severity in Sickle Cell Disease
Updated: 12/31/1969
Exploratory Studies of Psychophysical Pain Phenotyping and Genetic Variability in Sickle Cell Disease
Status: Enrolling
Updated: 12/31/1969
Genetics and Pain Severity in Sickle Cell Disease
Updated: 12/31/1969
Exploratory Studies of Psychophysical Pain Phenotyping and Genetic Variability in Sickle Cell Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Superficial Cervical Plexus Block for Pacemaker Insertion
Updated: 12/31/1969
Superficial Cervical Plexus Block for Pacemaker Insertion
Status: Enrolling
Updated: 12/31/1969
Superficial Cervical Plexus Block for Pacemaker Insertion
Updated: 12/31/1969
Superficial Cervical Plexus Block for Pacemaker Insertion
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials